These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21726837)

  • 1. Comparison of efficacy and safety of a standard versus a loading dose of clopidogrel for acute myocardial infarction in patients ≥ 75 years of age (from the FAST-MI registry).
    Puymirat E; Aïssaoui N; Coste P; Dentan G; Bataille V; Drouet E; Mulak G; Carrié D; Blanchard D; Simon T; Danchin N
    Am J Cardiol; 2011 Sep; 108(6):755-9. PubMed ID: 21726837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
    Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
    Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.
    Puymirat É; Aissaoui N; Silvain J; Bonello L; Cuisset T; Motreff P; Bataille V; Durand E; Cottin Y; Simon T; Danchin N;
    Arch Cardiovasc Dis; 2012; 105(6-7):347-54. PubMed ID: 22800719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
    Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kim JY; Jeong MH; Moon JH; Ahn YK; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae IH; Cho MC; Jang YS; Yoon JH; Seung KB; Park SJ;
    Am J Cardiol; 2012 Dec; 110(11):1598-606. PubMed ID: 22935526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registry.
    Puymirat E; Aïssaoui N; Collet JP; Chaib A; Bonnet JL; Bataille V; Drouet E; Mulak G; Ferrières J; Blanchard D; Simon T; Danchin N
    Int J Cardiol; 2013 Jun; 166(1):106-10. PubMed ID: 22078393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
    Cannon CP; Husted S; Harrington RA; Scirica BM; Emanuelsson H; Peters G; Storey RF;
    J Am Coll Cardiol; 2007 Nov; 50(19):1844-51. PubMed ID: 17980250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.
    Sørensen R; Abildstrøm SZ; Hansen PR; Hvelplund A; Andersson C; Charlot M; Fosbøl EL; Køber L; Madsen JK; Gislason GH; Torp-Pedersen C
    J Am Coll Cardiol; 2011 Mar; 57(10):1202-9. PubMed ID: 21371637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention.
    Bonello L; Lemesle G; De Labriolle A; Roy P; Steinberg DH; Pinto Slottow TL; Xue Z; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Nov; 102(10):1318-22. PubMed ID: 18993148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.
    Simon T; Steg PG; Gilard M; Blanchard D; Bonello L; Hanssen M; Lardoux H; Coste P; Lefèvre T; Drouet E; Mulak G; Bataille V; Ferrières J; Verstuyft C; Danchin N
    Circulation; 2011 Feb; 123(5):474-82. PubMed ID: 21262992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
    Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL;
    Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.
    Bonde L; Sorensen R; Fosbøl EL; Abildstrøm SZ; Hansen PR; Kober L; Schramm TK; Bretler DM; Weeke P; Olesen J; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2010 Mar; 55(13):1300-7. PubMed ID: 20338489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
    Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
    J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Carvajal J; Lehmann A; Lambert M; Bonnet JL; Alessi MC
    J Am Coll Cardiol; 2006 Oct; 48(7):1339-45. PubMed ID: 17010792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.